Evidence map›Paper›PMID 25714249›Full record

ArticleAnti-cancer drugs2015

Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases.

Yuan Yan, Jie Li, Jia Han, Ni Hou, Ying Song, Lei Dong

Open access · hybridAbstract read
In one paragraph

Article in Anti-cancer drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. CanFrontiers in pharmacology · 2026
    Article
  5. Article
  6. Chlorogenic acid induces hepatocellular carcinoma cell ferroptosisWorld journal of gastrointestinal oncology · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Frontiers in oncology · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Assessment of the Efficacy of Olive Leaf (Molecules (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Yuan YanDepartments of aGastroenterology bGeneral Surgery, The Second Affiliated Hospital cDepartment of Genetics and Molecular Biology, School of Medicine, Xi'an Jiaotong University dDepartment of Gastroenterology, Xi'an Central Hospital, Xi'an, China.
Jie Li
Jia Han
Ni Hou
Ying Song
Lei Dong
Xi'an Jiaotong University · CNFirst Hospital of Xi'an · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CNUniversity Gastroenterology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an urgent need to search for novel chemosensitizers in the field of cancer therapy. Chlorogenic acid (CGA), a type of polyphenol present in the diet, has many biological activities. The present study is designed to explore the influence of CGA on the effects of 5-fluorouracil (5-FU) on human hepatocellular carcinoma cells (HepG2 and Hep3B). Treatment with 5-FU induced the inhibition of hepatocellular carcinoma cells' proliferation, and the combined treatment with CGA enhanced this inhibition. 5-FU also increased the production of reactive oxygen species (ROS). The combination of 5-FU and CGA led to a more prominent production of ROS and significantly inactivated ERK1/2, although CGA and 5-FU exerted no significant changes when used alone. A previous report has shown that ROS are upstream mediators that inactivate ERK in hepatocellular carcinoma cells. Combined with our results, this indicates that the combination of 5-FU and CGA leads to the inactivation of ERK through the overproduction of ROS. This mediates the enhancement of 5-FU-induced inhibition of hepatocellular carcinoma cells' proliferation, that is, CGA sensitizes hepatocellular carcinoma cells to 5-FU treatment by the suppression of ERK activation through the overproduction of ROS. CGA has shown potential as a chemosensitizer of 5-FU chemotherapy in hepatocellular carcinoma.

Indexed as

Antineoplastic AgentsApoptosisCarcinoma, HepatocellularCell Line, TumorCell ProliferationCell SurvivalChlorogenic AcidDrug SynergismFluorouracilHumansLiver NeoplasmsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Reactive Oxygen SpeciesAntineoplastic AgentsChlorogenic AcidFluorouracilMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Reactive Oxygen Species

Identifiers

PMID25714249
PMCPMC4415958
OpenAlexW2003945985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.